Showing results (191-200 of 202) with videos related to
Sort By:
Pageof 21
Progress in Retinal and Eye Research|December 13, 2022
10q26 - The enigma in age-related macular degenerationDavid A Merle, Merve Sen, Angela Armento, et al.Public Health Genomics|April 17, 2010
Framing genomics, public health research and policy: points to considerBartha Maria Knoppers, T Leroux, H Doucet, et al.Scientific Reports|September 24, 2017
Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degenerationChloe M Stanton, Shyamanga Borooah, Camilla Drake, et al.Investigative Ophthalmology & Visual Science|December 22, 2023
Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5Randa T H Li, Alejandro J Roman, Alexander Sumaroka, et al.Plos One|February 21, 2024
HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based studyAmelia M Stanton, Ryan L Boyd, Conall O'Cleirigh, et al.Nature Communications|June 16, 2026
Disease-associated genetic variants can cause missense effects in tissue-specific protein isoformsGiovanna Weykopf, Mihaly Badonyi, Elias T Friman, et al.Investigative Ophthalmology & Visual Science|October 18, 2011
Complement factor D in age-related macular degenerationChloe M Stanton, John R W Yates, Anneke I den Hollander, et al.Journal of Public Health in Africa|November 7, 2024
Dynamic factors associated with COVID-19 vaccine uptake in Cameroon between 2021 and 2022Dora Tchiasso, Patricia Mendjime, Karl Njuwa Fai, et al.Human Molecular Genetics|July 23, 2013
Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degenerationMorad Ansari, Paul M McKeigue, Christine Skerka, et al.Plos One|January 26, 2010
Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's diseaseMinerva M Carrasquillo, Olivia Belbin, Fanggeng Zou, et al.Pageof 21